Dra. Edith Uresti Rivera

Sección: Medicina Molecular y Traslacional

	Regresar Nombre: Edith Elena Uresti Rivera Nacionalidad: Mexicana
ESTUDIOS Químico Farmacobiólogo (UASLP) Maestría en Biología Molecular (IPICYT) Doctorado en Ciencias en Biología Molecular (IPICYT). Posdoctorado en National Institute of Environmental Health Sciences (NIEHS). Stem Cell Toxicology Group, National Toxicology Program Laboratory. Research Triangle Park, NC, USA.
PUESTO DE TRABAJO 1) Profesor por asignatura en la Facultad de Ciencias Químicas, UASLP (2017 – hasta la actualidad).
DISTINCIONES 1) 2019-2022, Investigador Nacional Nivel I, Sistema Nacional de Investigadores, Área II: Biología y Química, CONACYT.
DIRECCIÓN DE TESIS DE POSGRADO Licenciatura: en proceso 1. Maestría: Concluidas 1, en proceso 1. Doctorado: en proceso 1. Comités tutoriales: 5 de maestría concluidas y 2 en proceso. 2 de doctorado concluidas y 2 en proceso.
ARTICULOS PUBLICADOS EN REVISTAS INDIZADAS 23 artículos (a noviembre de 2021).
CITAS a ARTÍCULOS PUBLICADOS e ÍNDICE h Citas: 674 (Scopus); 1012 (Google Scholar) Índice h: 8 ( Scopus); 10 (Google Scholar)
ARTICULOS PUBLICADOS EN REVISTAS INDIZADAS Expression of mBD4, mBD3 and CRAMP during type II collagen-induced arthritis/CIA and their association with inflammation and bone-remodeling markers. Mendez-Frausto G, Uresti-Rivera EE, Godina-Gonzalez S, Portales-Perez DP, Gonzalez-Amaro R, Garcia-Hernandez MH. Exp Mol Pathol. 2021 Sep 27;123:104689. doi: 10.1016/j.yexmp.2021.104689. Online ahead of print. 2. Clinical utility of ABCB1 and ABCG2 genotyping for assessing the clinical and pathological response to FAC therapy in Mexican breast cancer patients. Turiján-Espinoza E, Ruíz-Rodríguez VM, Uresti-Rivera EE, Martínez-Leija E, Zermeño-Nava JJ, Guel-Pañola A, Romano-Moreno S, Vargas-Morales JM, Portales-Pérez DP. Cancer Chemother Pharmacol. 2021 Jun;87(6):843-853. doi: 10.1007/s00280-021-04244-y. Epub 2021 Mar 19. 3. B regulatory cells associated with changes in biochemical and inflammatory parameters in normal-glycemic individuals, pre-diabetes and T2DM patients. Méndez-Frausto G, Romero-Aguilera G, Sanchez-Gutierrez R, García-Jacobo RE, Lara-Ramírez EE, Uresti-Rivera EE, González-Amaro R, Enciso-Moreno JA, García-Hernández MH. Diabetes Res Clin Pract. 2021 Mar;173:108692. doi: 10.1016/j.diabres.2021.108692. Epub 2021 Feb 8. 4. Decreased levels and activity of Sirt1 are modulated by increased miR-34a expression in adipose tissue mononuclear cells from subjects with overweight and obesity: A pilot study. Briones-Espinoza MJ, Cortés-García JD, Vega-Cárdenas M, Uresti-Rivera EU, Gómez-Otero A, López-López N, Mejía-Torres M, Portales-Pérez DP. Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1347-1354. doi: 10.1016/j.dsx.2020.07.014. Epub 2020 Jul 18. 5. Expression and activity of AIM2-inflammasome in rheumatoid arthritis patients. Méndez-Frausto G, Medina-Rosales MN, Uresti-Rivera EE, Baranda-Cándido L, Zapata-Zúñiga M, Bastián Y, González Amaro R, Enciso-Moreno JA, García-Hernández MH. Immunobiology. 2020 Mar;225(2):151880. doi: 10.1016/j.imbio.2019.11.015. Epub 2019 Dec 2. 6. Circulating miR-146a, miR-34a and miR-375 in type 2 diabetes patients, pre-diabetic and normal-glycaemic individuals in relation to β-cell function, insulin resistance and metabolic parameters. García-Jacobo RE, Uresti-Rivera EE, Portales-Pérez DP, González-Amaro R, Lara-Ramírez EE, Enciso-Moreno JA, García-Hernández MH. Clin Exp Pharmacol Physiol. 2019 Dec;46(12):1092-1100. doi: 10.1111/1440-1681.13147. Epub 2019 Aug 20. 7. Increased levels of adipose tissue-resident Th17 cells in obesity associated with miR-326. Vega-Cárdenas M, Uresti-Rivera EE, Cortés-García JD, Briones-Espinoza M, Ruíz-Rodríguez VM, Reynaga-Hernández E, Mendez-Mancilla A, Portales-Pérez DP. Immunol Lett. 2019 Jul;211:60-67. doi: 10.1016/j.imlet.2019.05.010. Epub 2019 May 25. 8. Expression and genotype-dependent catalytic activity of N-acetyltransferase 2 (NAT2) in human peripheral blood mononuclear cells and its modulation by Sirtuin 1. Salazar-González RA, Turiján-Espinoza E, Hein DW, Milán-Segovia RC, Uresti-Rivera EE, Portales-Pérez DP. Biochem Pharmacol. 2018 Oct;156:340-347. doi: 10.1016/j.bcp.2018.08.034. Epub 2018 Aug 25. 9. Frequency of regulatory B cells in adipose tissue and peripheral blood from individuals with overweight, obesity and normal-weight. García-Hernández MH, Rodríguez-Varela E, García-Jacobo RE, Hernández-De la Torre M, Uresti-Rivera EE, González-Amaro R, Portales-Pérez DP. Obes Res Clin Pract. 2018 Nov-Dec;12(6):513-519. doi: 10.1016/j.orcp.2018.07.001. Epub 2018 Aug 13. 10. Increased Levels of AIM2 and Circulating Mitochondrial DNA in Type 2 Diabetes. Cataño Cañizales YG, Uresti Rivera EE, García Jacobo RE, Portales Perez DP, Yadira B, Rodriguez Rivera JG, Amaro RG, Enciso Moreno JA, García Hernández MH. Iran J Immunol. 2018 Jun;15(2):142-155. 11. A pilot study of the modulation of sirtuins on arylamine N-acetyltransferase 1 and 2 enzymatic activity. Turiján-Espinoza E, Salazar-González RA, Uresti-Rivera EE, Hernández-Hernández GE, Ortega-Juárez M, Milán R, Portales-Pérez D. Acta Pharm Sin B. 2018 Mar;8(2):188-199. doi: 10.1016/j.apsb.2017.11.008. Epub 2017 Dec 30. 12. The presence of the 1068 G>A variant of P2X7 receptors is associated to an increase in IL-1Ra levels, insulin secretion and pancreatic β-cell function but not with glycemic control in type 2 diabetes patients. Uresti-Rivera EE, García-Jacobo RE, Méndez-Cabañas JA, Gaytan-Medina LE, Cortez-Espinosa N, Portales-Pérez DP, González-Amaro R, Enciso-Moreno JA, García-Hernández MH. Gene. 2018 Apr 30;652:1-6. doi: 10.1016/j.gene.2018.01.084. Epub 2018 Feb 6. Regresar

Regresar

Nombre: Edith Elena Uresti Rivera

Nacionalidad: Mexicana

ESTUDIOS

Químico Farmacobiólogo (UASLP)
Maestría en Biología Molecular (IPICYT)
Doctorado en Ciencias en Biología Molecular (IPICYT).
Posdoctorado en National Institute of Environmental Health Sciences (NIEHS). Stem Cell Toxicology Group, National Toxicology Program Laboratory. Research Triangle Park, NC, USA.

PUESTO DE TRABAJO

1) Profesor por asignatura en la Facultad de Ciencias Químicas, UASLP (2017 – hasta la actualidad).

DISTINCIONES

1) 2019-2022, Investigador Nacional Nivel I, Sistema Nacional de Investigadores, Área II: Biología y Química, CONACYT.

DIRECCIÓN DE TESIS DE POSGRADO

Licenciatura: en proceso 1.

Maestría: Concluidas 1, en proceso 1.

Doctorado: en proceso 1.

Comités tutoriales: 5 de maestría concluidas y 2 en proceso. 2 de doctorado concluidas y 2 en proceso.

ARTICULOS PUBLICADOS EN REVISTAS INDIZADAS

23 artículos (a noviembre de 2021).

CITAS a ARTÍCULOS PUBLICADOS e ÍNDICE h

Citas: 674 (Scopus); 1012 (Google Scholar)

Índice h: 8 ( Scopus); 10 (Google Scholar)

ARTICULOS PUBLICADOS EN REVISTAS INDIZADAS

Expression of mBD4, mBD3 and CRAMP during type II collagen-induced arthritis/CIA and their association with inflammation and bone-remodeling markers. Mendez-Frausto G, Uresti-Rivera EE, Godina-Gonzalez S, Portales-Perez DP, Gonzalez-Amaro R, Garcia-Hernandez MH. Exp Mol Pathol. 2021 Sep 27;123:104689. doi: 10.1016/j.yexmp.2021.104689. Online ahead of print.

2. Clinical utility of ABCB1 and ABCG2 genotyping for assessing the clinical and pathological response to FAC therapy in Mexican breast cancer patients. Turiján-Espinoza E, Ruíz-Rodríguez VM, Uresti-Rivera EE, Martínez-Leija E, Zermeño-Nava JJ, Guel-Pañola A, Romano-Moreno S, Vargas-Morales JM, Portales-Pérez DP. Cancer Chemother Pharmacol. 2021 Jun;87(6):843-853. doi: 10.1007/s00280-021-04244-y. Epub 2021 Mar 19.

3. B regulatory cells associated with changes in biochemical and inflammatory parameters in normal-glycemic individuals, pre-diabetes and T2DM patients. Méndez-Frausto G, Romero-Aguilera G, Sanchez-Gutierrez R, García-Jacobo RE, Lara-Ramírez EE, Uresti-Rivera EE, González-Amaro R, Enciso-Moreno JA, García-Hernández MH. Diabetes Res Clin Pract. 2021 Mar;173:108692. doi: 10.1016/j.diabres.2021.108692. Epub 2021 Feb 8.

4. Decreased levels and activity of Sirt1 are modulated by increased miR-34a expression in adipose tissue mononuclear cells from subjects with overweight and obesity: A pilot study. Briones-Espinoza MJ, Cortés-García JD, Vega-Cárdenas M, Uresti-Rivera EU, Gómez-Otero A, López-López N, Mejía-Torres M, Portales-Pérez DP. Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1347-1354. doi: 10.1016/j.dsx.2020.07.014. Epub 2020 Jul 18.

5. Expression and activity of AIM2-inflammasome in rheumatoid arthritis patients. Méndez-Frausto G, Medina-Rosales MN, Uresti-Rivera EE, Baranda-Cándido L, Zapata-Zúñiga M, Bastián Y, González Amaro R, Enciso-Moreno JA, García-Hernández MH. Immunobiology. 2020 Mar;225(2):151880. doi: 10.1016/j.imbio.2019.11.015. Epub 2019 Dec 2.

6. Circulating miR-146a, miR-34a and miR-375 in type 2 diabetes patients, pre-diabetic and normal-glycaemic individuals in relation to β-cell function, insulin resistance and metabolic parameters. García-Jacobo RE, Uresti-Rivera EE, Portales-Pérez DP, González-Amaro R, Lara-Ramírez EE, Enciso-Moreno JA, García-Hernández MH. Clin Exp Pharmacol Physiol. 2019 Dec;46(12):1092-1100. doi: 10.1111/1440-1681.13147. Epub 2019 Aug 20.

7. Increased levels of adipose tissue-resident Th17 cells in obesity associated with miR-326. Vega-Cárdenas M, Uresti-Rivera EE, Cortés-García JD, Briones-Espinoza M, Ruíz-Rodríguez VM, Reynaga-Hernández E, Mendez-Mancilla A, Portales-Pérez DP. Immunol Lett. 2019 Jul;211:60-67. doi: 10.1016/j.imlet.2019.05.010. Epub 2019 May 25.

8. Expression and genotype-dependent catalytic activity of N-acetyltransferase 2 (NAT2) in human peripheral blood mononuclear cells and its modulation by Sirtuin 1. Salazar-González RA, Turiján-Espinoza E, Hein DW, Milán-Segovia RC, Uresti-Rivera EE, Portales-Pérez DP. Biochem Pharmacol. 2018 Oct;156:340-347. doi: 10.1016/j.bcp.2018.08.034. Epub 2018 Aug 25.

9. Frequency of regulatory B cells in adipose tissue and peripheral blood from individuals with overweight, obesity and normal-weight. García-Hernández MH, Rodríguez-Varela E, García-Jacobo RE, Hernández-De la Torre M, Uresti-Rivera EE, González-Amaro R, Portales-Pérez DP. Obes Res Clin Pract. 2018 Nov-Dec;12(6):513-519. doi: 10.1016/j.orcp.2018.07.001. Epub 2018 Aug 13.

10. Increased Levels of AIM2 and Circulating Mitochondrial DNA in Type 2 Diabetes. Cataño Cañizales YG, Uresti Rivera EE, García Jacobo RE, Portales Perez DP, Yadira B, Rodriguez Rivera JG, Amaro RG, Enciso Moreno JA, García Hernández MH. Iran J Immunol. 2018 Jun;15(2):142-155.

11. A pilot study of the modulation of sirtuins on arylamine N-acetyltransferase 1 and 2 enzymatic activity. Turiján-Espinoza E, Salazar-González RA, Uresti-Rivera EE, Hernández-Hernández GE, Ortega-Juárez M, Milán R, Portales-Pérez D. Acta Pharm Sin B. 2018 Mar;8(2):188-199. doi: 10.1016/j.apsb.2017.11.008. Epub 2017 Dec 30.

12. The presence of the 1068 G>A variant of P2X7 receptors is associated to an increase in IL-1Ra levels, insulin secretion and pancreatic β-cell function but not with glycemic control in type 2 diabetes patients. Uresti-Rivera EE, García-Jacobo RE, Méndez-Cabañas JA, Gaytan-Medina LE, Cortez-Espinosa N, Portales-Pérez DP, González-Amaro R, Enciso-Moreno JA, García-Hernández MH. Gene. 2018 Apr 30;652:1-6. doi: 10.1016/j.gene.2018.01.084. Epub 2018 Feb 6.